Article
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.
Cancer medicine - 1 Jul 2024
Wang Yuekun, Xing Hao, Guo Xiaopeng, Chen Wenlin, Wang Yaning, Liang Tingyu, Wang Hai, Li Yilin, Jin Shanmu, Shi Yixin, Liu Delin, Yang Tianrui, Xia Yu, Li Junlin, Wu Jiaming, Liu Qianshu, Qu Tian, Guo Siying, Li Huanzhang, Zhang Kun, Wang Yu, Ma Wenbin
Abstract excerpt
BACKGROUND: The diagnosis of glioma has advanced since the release of the WHO 2021 classification with more molecular alterations involved in the integrated diagnostic pathways. Our study aimed to present our experience with the clinical features and management of astrocytoma, IDH mutant based on the latest WHO classification. METHODS: Patients diagnosed with astrocytoma, IDH-mutant based on the WHO 5th edition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.